These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29608750)

  • 21. Potential role of T2Candida in the management of empirical antifungal treatment in patients at high risk of candidaemia: a pilot single-centre study.
    Giannella M; Paolucci M; Roncarati G; Vandi G; Pascale R; Trapani F; Bartoletti M; Tedeschi S; Ambretti S; Lewis R; Re MC; Viale P
    J Antimicrob Chemother; 2018 Oct; 73(10):2856-2859. PubMed ID: 29939275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Invasive candidiasis and candidaemia in neonates and children: update on current guidelines.
    Tragiannidis A; Tsoulas C; Groll AH
    Mycoses; 2015 Jan; 58(1):10-21. PubMed ID: 25350572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.
    Posteraro B; Tumbarello M; De Pascale G; Liberto E; Vallecoccia MS; De Carolis E; Di Gravio V; Trecarichi EM; Sanguinetti M; Antonelli M
    J Antimicrob Chemother; 2016 Aug; 71(8):2262-9. PubMed ID: 27125554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis.
    Neoh CF; Liew D; Slavin MA; Marriott D; Chen SC; Morrissey O; Stewart K; Kong DC
    Intern Med J; 2013 Jun; 43(6):668-77. PubMed ID: 23461421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel.
    Clancy CJ; Pappas PG; Vazquez J; Judson MA; Kontoyiannis DP; Thompson GR; Garey KW; Reboli A; Greenberg RN; Apewokin S; Lyon GM; Ostrosky-Zeichner L; Wu AHB; Tobin E; Nguyen MH; Caliendo AM
    Clin Infect Dis; 2018 May; 66(11):1678-1686. PubMed ID: 29438475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Micafungin injection for the treatment of invasive candidiasis in pediatric patients under 4 months of age.
    Abdel-Haq N; Smith SM; Asmar BI
    Expert Rev Anti Infect Ther; 2022 Apr; 20(4):493-505. PubMed ID: 34882043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of candidaemia and invasive candidiasis in critically ill patients.
    Chahoud J; Kanafani ZA; Kanj SS
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S29-35. PubMed ID: 23664579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
    Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
    J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial.
    Mylonakis E; Zacharioudakis IM; Clancy CJ; Nguyen MH; Pappas PG
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Appropriate use of antifungals: impact of an antifungal stewardship program on the clinical outcome of candidaemia in a French University Hospital.
    Benoist H; Rodier S; de La Blanchardière A; Bonhomme J; Cormier H; Thibon P; Saint-Lorant G
    Infection; 2019 Jun; 47(3):435-440. PubMed ID: 30806974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis.
    Pfaller MA; Wolk DM; Lowery TJ
    Future Microbiol; 2016; 11(1):103-17. PubMed ID: 26371384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The economic impact of rapid Candida species identification by T2Candida among high-risk patients.
    Bilir SP; Ferrufino CP; Pfaller MA; Munakata J
    Future Microbiol; 2015; 10(7):1133-44. PubMed ID: 25848692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
    Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
    J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breakthrough candidaemia in the era of broad-spectrum antifungal therapies.
    Cuervo G; Garcia-Vidal C; Nucci M; Puchades F; Fernández-Ruiz M; Obed M; Manzur A; Gudiol C; Pemán J; Aguado JM; Ayats J; Carratalà J
    Clin Microbiol Infect; 2016 Feb; 22(2):181-188. PubMed ID: 26460064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Off-label use of T2Candida
    Cendejas-Bueno E; Peinado H; Baquero-Artigao F; Falces-Romero I; Calvo-Rey C; Banda-Montalvo L; García-Rodríguez J
    Future Microbiol; 2021 Jun; 16():619-621. PubMed ID: 34082566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).
    Chiotos K; Vendetti N; Zaoutis TE; Baddley J; Ostrosky-Zeichner L; Pappas P; Fisher BT
    J Antimicrob Chemother; 2016 Dec; 71(12):3536-3539. PubMed ID: 27494929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal stewardship with an emphasis on candidaemia.
    Capoor MR; Subudhi CP; Collier A; Bal AM
    J Glob Antimicrob Resist; 2019 Dec; 19():262-268. PubMed ID: 31195147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T2Candida magnetic resonance in patients with invasive candidiasis: Strengths and limitations.
    Zurl C; Prattes J; Zollner-Schwetz I; Valentin T; Rabensteiner J; Wunsch S; Hoenigl M; Krause R
    Med Mycol; 2020 Jul; 58(5):632-638. PubMed ID: 31613367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness Analysis of Multiplex PCR with Magnetic Resonance Detection versus Empiric or Blood Culture-Directed Therapy for Management of Suspected Candidemia.
    Walker B; Powers-Fletcher MV; Schmidt RL; Hanson KE
    J Clin Microbiol; 2016 Mar; 54(3):718-26. PubMed ID: 26739159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia.
    Theodore DA; Henneman AD; Loo A; Shields RK; Eschenauer G; Sobieszczyk ME; Kubin CJ
    J Antimicrob Chemother; 2024 Aug; 79(8):1877-1884. PubMed ID: 38831614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.